Bessemer Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3K Hold
108
– – ﹤0.01% 2349
2026
Q2
$3K Buy
108
+6
+6% +$170 ﹤0.01% 2349
2026
Q1
$3K Buy
102
+61
+149% +$2.02K ﹤0.01% 2315
2025
Q4
$1K Buy
+41
New +$1.32K ﹤0.01% 2469
2021
Q2
– Sell
-163
Closed -$13K – 1597
2021
Q1
$13K Buy
+163
New +$15K ﹤0.01% 1256
2020
Q4
– Sell
-284,210
Closed -$40.3M – 1494
2020
Q3
$40.3M Buy
284,210
+51,973
+22% +$8.66M 0.12% 165
2020
Q2
$45.8M Hold
232,237
– – 0.14% 145
2020
Q1
$45.5M Sell
232,237
-39,110
-14% -$8.42M 0.18% 134
2019
Q4
$56.1M Sell
271,347
-83,219
-23% -$15.4M 0.18% 138
2019
Q3
$54.1M Sell
354,566
-21,196
-6% -$3.47M 0.19% 138
2019
Q2
$48.4M Buy
+375,762
New +$44.6M 0.16% 150

Other funds holding LKFT

Bessemer Group's LKFT Position: Q3 2026 in Review

Bessemer Group held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q3 2026 at 108 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

Bessemer Group first reported a position in LKFT in Q2 2019 and has held it in 11 quarters since. The position peaked at $56.1M in Q4 2019. 67 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Bessemer Group held 108 shares of Lakefront Biotherapeutics American Depositary Shares worth $3K as of Q3 2026.
  • Bessemer Group left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #2349 holding.
  • Bessemer Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and has held it in 11 quarters since.
  • Bessemer Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $56.1M in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.